Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2025-12-25 @ 3:56 AM
NCT ID:
NCT01253902
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of ocular hypertension or open-angle glaucoma in at least 1 eye requiring treatment with an anti-glaucoma/ocular hypertensive medication
* Best corrected visual acuity score of 20/100 or better in both eyes
* Females on birth control pills must be on same type of pill and dose for at least 3 month
Exclusion Criteria:
* Use of Lumigan® 0.01%/Lumigan® RC, Lumigan®, Travatan® or Travatan Z® within 6 months
* History of or active ocular infection/inflammation (eg, uveitis)
* Punctal plug use
* Required use of ocular medications during the study other than study medication (intermittent use of certain types artificial tears acceptable)
* Intraocular surgery or glaucoma laser surgery in study eye(s) within 3 months
* History of corneal refractive laser surgery (eg, LASIK, LASEK) in study eye(s)
* Planned contact lens wear during study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01253902
Study Brief:
Protocol Section:
NCT01253902